News

Palliative care programs could be a way to improve the quality of end-of-life care for patients who die in the hospital.

In a new study, investigators found that 40 mg and 60 mg lumateperone is clinically safe to treat schizophrenia.

An analysis of the CARDIA study revealed BMI in young adulthood served as a better predictor of obesity up to 25 years in the future than polygenic risk scores.

New findings show patients with HDHPs are more likely to skip inhaler therapy due to costs, and are therefore more frequently hospitalized.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

A panel that includes patients, clinicians, and methodologists create a new set of recommendations for treating gastrointestinal bleeding prophylaxis.

Investigators identified 7 healthcare quality indicators, “the ideal clinical pathway,” for patients with rheumatoid arthritis to reduce the risk of birth complications.

Investigators examine new data exploring the link between antipsychotic use and negative outcomes for hospitalized adults.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A new study examining rates of venous thromboembolism revealed children receiving PICCs as opposed to CVCs were at an increased risk of blood clots.

The American College of Physicians has released guidelines, which include 4 new recommendations, for the treatment of age-related low testosterone in men.

A new study from George Mason University is offering additional insight into the impact of e-cigarette and combustible cigarette use on a person's risk of stroke.

Investigators look at persistent symptoms for GERD patients taking proton pump inhibitors.

The tweet chat returns for a special crossover collaboration with a popular health data organization.

A study from investigators at UCLA has identified a biomarker investigators suggest can help identify stable heart failure patients at an increased risk of death within the next 3 years.

Novo Nordisk announced the US FDA's approval of insulin aspart injection 100 u/mL (Fiasp) for glycemic control in children in a press release on Monday morning.

A long-term comparison trial with smokers motivated to quit show the combination of alternative nicotine products could slightly and safely improve cessation.

Doctors are prone to workplace gaffes like anyone else. Here's a list of the funniest ones yet.

Northwell Health will focus on 2 different clinical strategies for monitoring and treating severe traumatic brain injuries.

A recent study examining 140 Australians found alcohol abstinence reduced the recurrence and burden of atrial fibrillation in regular drinkers between the ages of 18 and 85 years old.

The chatbot could provide information to patients about the procedure whenever and wherever they want.

A specific allele could help predict whether a patient will develop anti-drug antibodies to infliximab and adalimumab for patients with Crohn’s disease.

Patients who presented at the emergency department with deliberate self-harm were more likely to have suicide mortality than those with suicidal ideation or other concerns.

A comparison of virtual training to in-person education showed the former was noninferior to the latter among patients with asthma or COPD.

Increased levels of pyrethroid insecticide exposure was linked to increased in all-cause mortality, as well as increases in mortality from cancer and cardiovascular disease in a recent study from the University of Iowa.

Investigators test a new drug for geriatric patients with insomnia disorder.

While mental health is declining, physical and general health are remaining the same or improving in the aging population.

In a new study, a team of investigators use new imaging techniques to accurately predict brain tissue damage for patients with Alzheimer disease.

The US Food and Drug Administration has announced a comprehensive ban on flavored, pod-based e-cigarette cartridges earlier this week.

Investigators analyzed Medicare fee-for-service beneficiaries and found that current measures do not show high- and low-performing facilities.